These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3101979)

  • 1. Chronic administration of desipramine or nialamide decreases wet-dog shakes in rats produced by the TRH-analog MK-771.
    Sills MA; Jacobowitz DM
    Brain Res; 1987 Jan; 401(1):195-9. PubMed ID: 3101979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central muscarinic cholinergic antagonists block wet-dog shakes produced by the TRH analog MK-771 in the rat.
    Sills MA; Mellow AM; Sunderland T; Jacobowitz DM
    Brain Res; 1988 Jun; 453(1-2):385-8. PubMed ID: 3135919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of rats with the TRH analog MK-771. Down-regulation of TRH receptors and behavioral tolerance.
    Simasko SM; Horita A
    Neuropharmacology; 1985 Feb; 24(2):157-65. PubMed ID: 2986033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute and chronic effects of intrathecal galanin on behavioural and biochemical markers of spinal motor function in adult rats.
    Fone KC; Dixon DM
    Brain Res; 1991 Mar; 544(1):118-25. PubMed ID: 1713112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intrathecal proctolin administration on the behaviour evoked by the thyrotrophin-releasing hormone (TRH) analogue (RX 77368) and the indoleamine, TRH, substance P and calcitonin gene-related peptide levels and choline acetyltransferase activity in the rat spinal cord.
    Fone KC; Johnson JV; Bennett GW; Marsden CA
    Brain Res; 1988 Sep; 460(1):22-8. PubMed ID: 2464406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of catecholaminergic neurones and alpha-adrenoceptors in the wet-dog shake and forepaw licking behaviour produced by the intrathecal injection of an analogue of thyrotrophin-releasing hormone (CG 3509).
    Fone KC; Bennett GW; Marsden CA
    Neuropharmacology; 1987 Aug; 26(8):1147-55. PubMed ID: 2889164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of wet-dog shakes by intracerebral 'acid' TRH in rats.
    Boschi G; Launay N; Rips R
    Neurosci Lett; 1980 Feb; 16(2):209-12. PubMed ID: 6820479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MK-771 antagonizes the enhanced response to apomorphine in rats treated chronically with haloperidol - implications for tardive dyskinesia.
    Yarbrough GG; Faison EP; Antolik EK
    Neurosci Lett; 1982 Dec; 34(3):321-3. PubMed ID: 6819493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of behaviorally active doses of thyrotropin-releasing hormone and its analog MK-771 on dopaminergic neuronal systems in the brain of the rat.
    Yamada K; Demarest KT; Moore KE
    Neuropharmacology; 1984 Jul; 23(7A):735-9. PubMed ID: 6433220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [TRH and its analog (DN-1417). Effects on central dopaminergic system-dependent behaviors in rats and mice].
    Miyamoto M; Saji Y; Nagawa Y
    Nihon Yakurigaku Zasshi; 1985 Mar; 85(3):129-41. PubMed ID: 3924793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The regulation of TRH and serotonin receptors: chronic TRH and analog administration in the rat.
    Pranzatelli MR; Dailey A; Markush S
    J Recept Res; 1988; 8(5):667-81. PubMed ID: 2839679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of thyrotropin-releasing hormone analogues on body shaking and prolactin levels in estrogen-primed and nonprimed rats.
    Yamada K; Kumagai M; Nagashima M; Matsuo N; Furukawa T
    Arch Int Pharmacodyn Ther; 1989; 297():235-46. PubMed ID: 2499289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyrotropin-releasing hormone receptor activation in the spinal cord increases blood pressure and sympathetic tone to the vasculature and the adrenals.
    Helke CJ; Phillips ET
    J Pharmacol Exp Ther; 1988 Apr; 245(1):41-6. PubMed ID: 2834544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential anti-depressive effects of thyrotropin releasing hormone (TRH) and its analogues.
    Ogawa N; Mizuno S; Mori A; Nukina I; Ota Z; Yamamoto M
    Peptides; 1984; 5(4):743-6. PubMed ID: 6436797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemically applied thyrotropin-releasing hormone (TRH) modifies spontaneous behaviour of rats.
    Arnold R; Klingberg F; Schäker W
    Biomed Biochim Acta; 1991; 50(12):1217-24. PubMed ID: 1824539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of TRH and D-Ala2-metenkephalinamide on hippocampal electrical activity and behavior in the unanesthetized rat.
    Drust EG; Crawford IL
    Peptides; 1983; 4(2):239-43. PubMed ID: 6413957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of wet-dog shaking in rats by analogues and metabolites of thyrotrophin-releasing hormone (TRH).
    Webster VA; Griffiths EC; Slater P
    Regul Pept; 1982 Dec; 5(1):43-51. PubMed ID: 6820171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinal effects of chronic intrathecal administration of the thyrotrophin-releasing hormone analogue (CG 3509) in rats.
    Fone KC; Dix P; Tomlinson DR; Bennett GW; Marsden CA
    Brain Res; 1988 Jul; 455(1):157-61. PubMed ID: 2458166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyrotropin-releasing hormone and its analog MK-771 increase the cerebroventricular perfusate content of dihydroxyphenylacetic acid.
    Nielsen JA; Moore KE
    J Neurochem; 1984 Aug; 43(2):593-6. PubMed ID: 6429282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ineffectiveness of desipramine pretreatment on behavioral effects of 6-hydroxydopamine in nialamide-pretreated rats.
    Vetulani J; Reichenberg K; Wiszniowska G
    Psychopharmacologia; 1974; 38(2):173-80. PubMed ID: 4460073
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.